The Guardian: Mergers & Acquisitions

MARCH 19, 2024

The Anglo-Swedish company struck an agreement to acquire Fusion Pharmaceuticals, which is developing next-generation radioconjugates that offer an alternative to chemotherapy and radiotherapy.

Pharmaceutical 96

Pharmaceutical Portfolio Acquisitions Business 96

Sun Acquisitions

FEBRUARY 6, 2023

CHICAGO, IL ­- February 6, 2023 – Sun Acquisitions is pleased to announce the successful sale of Trouvaille Med Spa to MedSpa Partners Inc. Through the acquisition of Trouvaille Med Spa, MedSpa Partners Inc. Through the acquisition of Trouvaille Med Spa, MedSpa Partners Inc. About MedSpa Partners Inc.

Sale 52

Sale Acquisitions Mergers and Acquisitions Medical 52

How2Exit

OCTOBER 21, 2024

- Watch Here About the Guest(s): Nicholas Hulewsky is a seasoned entrepreneur and investor with a rich background in healthcare and mergers and acquisitions. The discussion delves into Nicholas's investment philosophy and approach to building a diverse portfolio within his hold company.

Mergers and Acquisitions 130

Mergers and Acquisitions Acquisitions Healthcare Business 130

Global Newswire by Notified: M&A

JANUARY 3, 2024

03, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it closed the acquisition of LimaCorporate S.p.A. WILMINGTON, Del.,

Acquisitions 40

Acquisitions Medical Portfolio Corporation 40

Focus Investment Banking

SEPTEMBER 17, 2024

The platform includes the acquisitions of GEM Manufacturing, Coining MFG, National Manufacturing Co. Targeting sectors with rigorous technical specifications, regulatory compliance standards, and exacting quality requirements, MSK serves customers primarily in the medical, aerospace & defense and telecommunications end markets.

Investment Banking 52

Investment Banking Acquisitions Investment Bank 52

Focus Investment Banking

MAY 31, 2024

Serving a variety of end markets, including aerospace & defense, electronics and industrials, National offers especially deep experience in the medical end market across various implantable devices, including pacemakers, neuromodulation devices, defibrillators, batteries and capacitors. appeared first on FOCUS.

Investment Banking 52

Investment Banking Manufacturing Bank Banking 52

Focus Investment Banking

JULY 20, 2023

Coining primarily serves the aerospace & defense, medical, electronics and semiconductor end markets for a variety of product types and applications, including microelectronic and sonic packages, sensors, implantable devices, connectors, terminals, solder cups, thermocouple pins and seal headers. director and owner of Coining and PMP.

Investment Banking 52

Investment Banking Manufacturing Bank Banking 52

Sun Acquisitions

JUNE 5, 2024

Sun Acquisitions has seen firsthand in recent years the dynamic landscape of the medical spa industry and its growth strategies often pivot on innovative approaches to expand clientele and service offerings. Industry thought leaders emphasize the importance of cultural fit between the acquiring and acquired companies.

M&A 52

M&A Mergers and Acquisitions Medical Acquisitions 52

Software Equity Group

MARCH 26, 2024

While these are just a handful of reasons why PEs love SaaS companies , it’s no wonder that top PE firms continue to focus on SaaS acquisitions. Main Capital has made 215 total investments since its founding, with current assets under management (AUM) of $2.37B and an active portfolio of 47 firms, with a median valuation of $10.25M.

Private Equity 52

Private Equity Equities Investment Portfolio 52

Sun Acquisitions

AUGUST 2, 2024

In recent years, Sun Acquisitions has witnessed remarkable growth in the MedSpa industry. Mergers and acquisitions (M&A) present a strategic avenue for MedSpas to scale their operations effectively. This acquisition allowed SkinSpirit to expand its service offerings and geographic presence.

M&A 52

M&A Management Mergers and Acquisitions Acquisitions 52

How2Exit

JUNE 19, 2023

John Prothrow had a background in mergers and acquisitions and had worked on the buy side of transactions. He had made some good friends and close colleagues in the field and had seen how they raised funds to buy a small portfolio of businesses. The brand also receives many medical referrals from podiatrists and other foot specialists.

Mergers and Acquisitions 130

Mergers and Acquisitions Business IT Acquisitions 130

Tyton Partners

APRIL 10, 2024

ISP Schools is a portfolio company of OMERS Private Equity. Achieve Partners’ social impact focus and deep experience in the digital transformation of education makes them the perfect partner for Elentra to continue to scale its purpose-built platform, and acquire other solutions, to best serve medical and allied health institutions globally.

Education 52

Education Medical Private Equity Equities 52

Tyton Partners

FEBRUARY 3, 2025

Should you wish to gain deeper insights into emerging trends within your core market, or require assistance with strategic and financial decisions to position your company for future growth, investment, or acquisition, please do not hesitate to contact us.

Education 52

Education Sale Investors Medical 52

Growth Business

NOVEMBER 23, 2023

The fund will not invest in hardware, medical devices or consumer social networks. The Notion portfolio includes Dixa, GoCardless, Mews, Paddle, Unbabel and Yulife. Wayra UK Telefónica’s innovation arm with more than 550 active portfolio companies, 35% of which are working with Telefónica.

Investment 111

Investment Funds Capital Business 111

How2Exit

MAY 9, 2023

Concept 2: DSOs and MSOs Buy Practices One of the topics discussed on the How to Exit podcast is the purchase of dental and medical practices by Dental Service Organizations (DSOs) and Medical Service Organizations (MSOs). There is no requirement to set up an MSO or DSO for the licensed medical professional.

Business 130

Business Investment IT Economics 130

Mergers and Inquisitions

NOVEMBER 1, 2023

The short answer to #1 is that healthcare private equity firms operate in specific verticals with stable-ish cash flows, such as healthcare services, nursing facilities, medical devices, equipment, and healthcare IT. They do not invest in risky biotech startups attempting to cure cancer (at least not within their traditional PE portfolios).

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Focus Investment Banking

APRIL 1, 2024

Most platforms are seeking acquisitions in their home regions and are especially interested in larger, more diversified practices. All PPM organizations, including those in ENT & allergy, are designed to acquire, operate, and grow medical practices. growing solely through acquisitions).

Private Equity 52

Private Equity Equities Negotiation Investment 52

Focus Investment Banking

MARCH 28, 2024

A typical ophthalmology PPM was founded in 2018 and has completed ten total acquisitions since (and thus, is now partnered with ten practices). Exits” – where private equity firms sell a PPM company from their portfolio – have also been very limited. Other PPMs (the majority, in our opinion) are still aggressively seeking acquisitions.

Private Equity 52

Private Equity Equities Valuation Acquisitions 52

Cooley M&A

JANUARY 23, 2024

For example, in the biopharma space, AbbVie, Bristol Myers Squibb, AstraZeneca, and Roche each announced multiple big-ticket acquisitions in the fourth quarter – including Abbvie’s acquisition of ImmunoGen for $10.1 billion; Bristol Myer Squibb’s acquisition of RayzeBio for $4.1 billion and Cerevel Therapeutics for $8.7

M&A 52

M&A Mergers and Acquisitions Acquisitions Pharmaceutical 52

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2023

The year started off with a bang, with mega-deals such as Microsoft’s pending $69 billion acquisition of Activision Blizzard, Elon Musk’s $44 billion acquisition of Twitter and Broadcom’s pending $61 billion acquisition of VMware inked in quick succession. Tech M&A in 2022 was a tale of two halves.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Focus Investment Banking

FEBRUARY 11, 2025

McKessons acquisition of PRISM Vision Group is an important milestone for private equitys investments in optometry practices. PRISM was founded in 2018 with Quad-C Managements acquisition of NJ Retina, a large Retina practice in New Jersey. Since then, PRISM has partnered with more than 20 ophthalmology groups throughout the Northeast.

Private Equity 52

Private Equity Healthcare Equities Medical 52

Mergers and Inquisitions

MARCH 5, 2025

Biotech Hedge Funds Definition: Biotech hedge funds bet for or against public biopharmaceutical companies, typically based on catalysts such as clinical trial results, acquisitions, and liquidations; many funds focus on early-stage companies, but some also invest in platform companies, and some also make private-market investments.

Funds 64

Funds Healthcare Mergers and Acquisitions Valuation 64

Cooley M&A

JANUARY 22, 2025

billion acquisition of Alpine Immune; by contrast, there were eight US biotech acquisitions exceeding $5 billion in 2023. 2024 saw companies focusing on internal research and development, innovative partnerships, and targeted bolt-on asset acquisitions to bolster their pipelines. from 2023. [1]

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64

Cooley M&A

JANUARY 25, 2024

billion tie-up between Inmarsat and Viasat was cleared by both regulators, Adobe’s $20 billion proposed acquisition of Figma was abandoned in December 2023 following regulatory pressure. For example, while the $7.3

M&A 52

M&A Mergers and Acquisitions Investment Government 52

InvestmentBank.com

MAY 18, 2021

In 2012, 25% of senior citizens had to declare bankruptcy due to medical expenses or were forced to mortgage their residences. The healthcare industry is formed of numerous subsectors including pharmaceutical services, diagnostics, medical technologies, and managed healthcare.

Healthcare 40

Healthcare M&A Valuation Hospitality 40